Parkinson’s care demands swift attention
Saturday, April 11, was commemorated globally as World Parkinson’s Day, with the observance of the day once again drawing attention to a growing but often under-recognised health challenge in our country.
While Parkinson’s disease may not command the same public urgency as infectious diseases, its steady rise, debilitating impact and long-term care make it a critical public health concern that requires deliberate, coordinated action.
Parkinson’s disease is the second most common neurodegenerative disorder globally, affecting over 10 million people.
In Ghana, though comprehensive national data remains limited, hospital-based figures suggest it accounts for a significant proportion of neurological cases, with most patients diagnosed around the age of 60 and above.
This alone signals a looming challenge, especially as the country’s population gradually ages.
Although the exact cause of Parkinson’s disease is not fully understood, scientific evidence points to a combination of genetic and environmental factors.
The disease occurs when nerve cells in the brain that produce dopamine—a chemical essential for smooth and coordinated muscle movements—begin to degenerate.
Age remains the strongest risk factor. Individuals above 60 years are particularly vulnerable, though early-onset cases can occur.
Genetics also plays a role, especially in individuals with a family history of the disease. Environmental exposures—such as prolonged contact with pesticides, herbicides and industrial toxins—have also been linked to increased risk.
Lifestyle factors may further contribute to the condition.
While not direct causes, physical inactivity, poor diet and limited mental engagement can accelerate neurological decline.
This underscores the importance of preventive health behaviours across the lifespan.
One of the most pressing issues in Ghana is delayed diagnosis. Early symptoms—such as tremors, stiffness, slowed movement and balance problems—are often overlooked or mistaken for normal ageing.
The Daily Graphic notes that in some cases, cultural interpretations may even attribute symptoms to spiritual causes, delaying medical intervention.
Compounding this challenge is the severe shortage of specialists.
With far fewer neurologists than recommended by global standards, many patients rely on general practitioners who may not always have specialised training in neurological conditions.
This brings to sharp focus the urgent need to strengthen capacity at the primary healthcare level.
Early diagnosis is crucial in managing the condition. When identified in its initial stages, Parkinson’s disease can be managed more effectively, slowing progression and improving quality of life.
Public awareness campaigns must therefore prioritise educating citizens on early warning signs and the importance of seeking prompt medical attention.
While Parkinson’s disease cannot yet be cured, a range of interventions can significantly improve patient outcomes.
Prevention efforts should focus on reducing exposure to environmental toxins, promoting healthy lifestyles, and encouraging regular medical check-ups, especially for older adults.
At the policy level, strengthening primary health care is key in tackling the disease.
Our frontline health workers must be trained to recognise symptoms and initiate early treatment to bridge the specialist gap.
Access to diagnostic tools and essential medications through the National Health Insurance Scheme (NHIS) must also be expanded.
We note further that physiotherapy, occupational therapy, and speech therapy services would help patients maintain independence, manage symptoms, and preserve dignity.
Everyone must realise that Parkinson’s disease does not affect patients alone; it also places emotional, physical, and financial strain on families.
Social support systems, caregiver training, and mental health services must therefore be integrated into the broader care framework.
In doing this, those most at risk—older adults, individuals with a family history of the disease, and people exposed to environmental toxins—must be specifically targeted in awareness and prevention efforts.
Routine screenings, community outreach, and workplace safety regulations can all play a role in reducing risk.
Ultimately, addressing Parkinson’s disease requires more than medical intervention—it demands a societal shift.
Government, healthcare providers, civil society, and communities must work together to build a system that prioritises early detection, equitable access to care, and the dignity of every patient.
How we respond as a country will reflect not only the strength of our health system but also its commitment to protecting the most vulnerable among us.
